Envonalkib

DB21585ExperimentalSmall molecule

Envonalkib is a small molecule drug. The usage of the INN stem '-alkib' in the name indicates that Envonalkib is a ALK (anaplastic lymphoma kinase) inhibitor. Envonalkib has a monoisotopic...

Mechanism: Pharmacologically active on ALK tyrosine kinase receptor
Curator reviewed
Formula / weight: C₂₄H₂₆Cl₂FN₅O₂ · 506.4 g/mol (avg)

Resolves to

Compound

UNIIQB7KTQ7VW9CAS1621519-26-3ChEMBLCHEMBL5095063ChEBI758648PubChem76899983

Structure

InChIKeyBVGDAZBTIVRTGO-UONOGXRCSA-NSMILESCOC1=C(C=NC(=C1)N1CCNC[C@@H]1C)C1=CC(O[C@H](C)C2=C(Cl)C(F)=CC=C2Cl)=C(N)N=C1

Targets

Q9UM73ALK

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Envonalkib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account